Proceedings of the 6th International Conference on Financial Innovation and Economic Development (ICFIED 2021)

The Impact of the Coronavirus on Chinese Pharmaceutical Industry

Authors
Haolang Liu
Corresponding Author
Haolang Liu
Available Online 22 March 2021.
DOI
https://doi.org/10.2991/aebmr.k.210319.010How to use a DOI?
Keywords
China, coronavirus, Pharmaceutical industry
Abstract
The outbreak of the new crown pneumonia epidemic has brought impact and changes to the lives of all people. It also puts forward higher requirements on the production capacity and creativity of Chinese pharmaceutical industry. Under the epidemic, the development of Chinese pharmaceutical industry is facing good opportunities and ushered in bright prospects. But it is undeniable that there are still some problems and challenges that need to be resolved. A simple analysis of the current situation and development opportunities of Chinese pharmaceutical industry is carried out. Some problems and challenges in its development process are explored, and some relevant countermeasures are put forward to promote the healthy and rapid development of Chinese pharmaceutical industry.
Open Access
This is an open access article distributed under the CC BY-NC license.

Download article (PDF)

Cite this article

TY  - CONF
AU  - Haolang Liu
PY  - 2021
DA  - 2021/03/22
TI  - The Impact of the Coronavirus on Chinese Pharmaceutical Industry
BT  - Proceedings of the 6th International Conference on Financial Innovation and Economic Development (ICFIED 2021)
PB  - Atlantis Press
SP  - 51
EP  - 56
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.210319.010
DO  - https://doi.org/10.2991/aebmr.k.210319.010
ID  - Liu2021
ER  -